94
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Stability of cyclosporine-loaded poly-X-caprolactone nanoparticles

, , , &
Pages 777-787 | Received 20 Oct 1996, Accepted 20 Jan 1997, Published online: 26 Jun 2009

References

  • Aso Y., Yoshioka S., Terao T. Effects of storage on the physicochemical properties and release characteristics of progesterone-loaded poly(L-lactide) microspheres. International Journal of Pharmaceutics 1993; 93: 153–159
  • Auvillan M., Cave G., Fessi H., Devissa Cuet J. P. Lyophilisation de vectors colloidaux submicroniques. S.T.P. Pharma 1989; 5: 738–744
  • Bonduelle S., Pimienta C., Benoit J. P., Lenaerts V. Body distribution in mice of intravenously injected radiolabelled cyclosporin associated with polyisohexylcyanoacrylate nanocapsules or nanospheres. European Journal of Pharmaceutics and Biopharmaceutics 1995; 41: 27–30
  • Brannon-Peppas L. Recent advances in the use of biodegradable microparticles and nanoparticles in controlled drug delivery. International Journal of Pharmaceutics 1995; 116: 1–9
  • Buri P., Puisieux F., Doelker E., Benoit J. P. Formes Pharmaceutiques Nouvelles. Tec. & Doc. Lavoisier, Paris 1985; 42
  • Coffin M., McGinity J. Biodegradable pseudolatex: the chemical stability of poly(DL-lactide) and poly(∑-caprolactone) nanoparticles in aqueous media. Pharmaceutical Research 1992; 9(2)200–205
  • Couvreur P., Dubernet C., Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. European Journal of Pharmaceutics and Biopharmaceutics 1995; 41: 2–13
  • Chacon M., BerCes L., Molpeceres J., Aberturas M. R., Guzman M. Optimized preparation of poly d (lactic-glycolic) microspheres and nanoparticles for oral administration. International Journal of Pharmaceutics 1996; 141: 81–91
  • FaulIIs D., Goa K. L., Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993; 45(6)953–1040
  • FeW H., Puisieux F., Devissa Cuet J. P., Ammoury N., Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. International Journal of Pharmaceutics 1989; 55: 4
  • Gangrade N., Price J. C. Simple gas chromatographic headspace analysis of residual organic solvent in microspheres. Journal of Pharmaceutical Sciences 1992; 81(2)201–202
  • Geneidi A. S., Hamacher H. Physical characterization and dissolution profiles of spironolactone and diazepam coprecipitates. Pharmaceutical Industry 1980; 42(3)315–319
  • Guterres S. s., FeW H., Barratt G., Devissaguet J. P., Puisieux F. Poly (m-lactide) nanocapsules containing diclofenac: I. Formulation and stability study. International Journal of Pharmaceutics 1995; 113: 57–63
  • Guzman M., Molpeceres J., Garcia F., Aberturas M. R. Preparation, characterization and in vitro drug release of poly-∑-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres. Journal of Microencapsulation 1996; 13(1)25–39
  • Guziuan M., Molpeceres J., Garcia F., Aberturas M. R., Rodriguez M. The formation and characterization of CyA-loaded nanoparticles. Journal of Pharmaceutical Science 1993; 82: 498–502
  • Kreuter J. Evaluation of nanoparticles as drug-delivery systems I: Preparation methods. Pharmaceutica Acta Helvetie 1983; 58: 196–209
  • Lin W. J., Flanagan D. R., Linhardt R. J. Accelerated degradation of Poly(∑-caprolactone) by organic amines. Pharmaceutical Research 1994; 11: 1030–1034
  • Losa C. Diseño y evaluación hiofarmacéutica de nuevas formulaciones de administracion ocular: Nanopartículas de amicacina y nanocápsulas de metipranolol. Santiago de Compostela. 1991; 128, Doctoral thesis
  • Molpeceres J., Guzman M., Aberturas M. R., Chacon M., Berges L. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement. Journal of Pharmaceutical Science 1992; 85: 206–213
  • MolIWeres J., Guzman M., Bustamante P., Aberturas M. R. Exothermic-endothermic heat of solution shift of cyclosporine A related to Poloxamer 188 hehaviour in aqueous solutions. International Journal of Pharmaceutics 1995; 130: 75–81
  • Pitt C. G. Poly-∑-caprolactone and its copolymers. Biodegradable Polymers as Drug Delivery Systems, M. Chasin, R. Langer. Marcel Dekker, New York 1990; 71–120
  • Sanchez A., Alonso M. J. Poly(D -lactide-co-glycolide) micro and nanospheres as a way to prolong hlood/plasma levels of subcutaneously injected cyclosporin A. European Journal of Pharmaceutics and Biopharmaceutics 1995; 41: 31–37
  • Zhou Z., Chu B. J. Light scattering study on the association behaviour of trihlock polymers of ethylene oxide and propylene oxide in aqueous solutions. Journal of Colloid Interface Science 1988; 126: 171–180

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.